India Globalization Capital, Inc. (NYSE American: IGC) declared that US Patent and Trademark Office (USPTO) has awarded the firm one more patent. The firm has acquired the patent for cannabinoid composition and technique for curing pain in sufferers with Psoriatic Arthritis, Fibromyalgia, Scleroderma, and other conditions.
India Globalization Capital, Inc. (NYSE American: IGC) shares were plunged 3.07% as they lost -0.05 during the trading session of Friday. India Globalization Capital, Inc. (NYSE American: IGC) share price went from a low point around $0.26 to briefly over $4.50 in past 52 weeks, though shares have since pulled back to $1.58. IGC market cap has remained high, reaching $65.24 million at the time of writing.
IGC has acquired the patent #10,933,082 on March 2, 2021. The firm has applied for the patent on October 1, 2018. The latest patent authorization complements the current patent portfolio of the firm, which comprises patent issuing by the USPTO for seizure disorders and eating disorders.